Delivery Order SPE2DR25D1200-SPE2DR26FMG0M
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units on July 24, 2025, with a ceiling value of $12,221.66 and a firm fixed price structure. The delivery order represents a competitive award with no set-aside designation and is set for completion by July 25, 2025. This award falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Lidocaine 5% Patch 30S, a topical pain relief medication. This firm fixed price delivery order, valued at $12.3K, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion and extends through December 2026. The award was made on a competitive, non-set-aside...
- The Defense Logistics Agency awarded a $3,241.94 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of October 31, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,361.04 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Lidocaine 5% Patch 30s. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is expected to be completed by September 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30S on September 12, 2025, with a ceiling value of $1,414.08 and an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,418.56 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,357.45 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of November 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,596.64 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30S, with an ultimate completion date of November 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on October 31, 2025. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30S under a firm fixed-price contract valued at $4,928.37, with an ultimate completion date of October 23, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The product will be...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $5,131.45. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded without any set-aside designation. The award falls under AmerisourceBergen's existing Indefinite...
- SPE2DR25D1200Indefinite Delivery Contract
- SPE2DR25D1200-SPE2DR26FMG0MDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This competitive award, valued at $1,506.89 with firm fixed pricing, was issued on October 28, 2025, and is scheduled for completion by October 29, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 and extends through December 2026. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive pharmaceutical and medical supply portfolio. The company's SPE2DX contract with DLA Troop Support Medical functions as a global pharmaceutical support vehicle enabling the supply of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. Through this prime contract vehicle, AmerisourceBergen supplies products to federal customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key provider within the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/28/25 |